Jefferies Group LLC reaffirmed their buy rating on shares of Stericycle, Inc. (NASDAQ:SRCL) in a research note released on Thursday, July 13th. They currently have a $108.00 price target on the business services provider’s stock.

A number of other equities research analysts also recently weighed in on SRCL. Robert W. Baird downgraded shares of Stericycle from a neutral rating to an underperform rating and lowered their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 15th. Zacks Investment Research upgraded shares of Stericycle from a hold rating to a buy rating and set a $85.00 target price for the company in a research report on Wednesday, July 5th. BMO Capital Markets assumed coverage on shares of Stericycle in a research report on Thursday, June 29th. They issued a market perform rating and a $81.00 target price for the company. Barclays PLC assumed coverage on shares of Stericycle in a research note on Thursday, April 13th. They issued an overweight rating and a $100.00 price target for the company. Finally, Deutsche Bank AG reduced their price target on shares of Stericycle from $14.00 to $10.00 and set a buy rating for the company in a research note on Monday, May 15th. Four analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus target price of $81.15.

Stericycle (NASDAQ SRCL) opened at 78.66 on Thursday. The firm has a market cap of $6.71 billion, a PE ratio of 40.99 and a beta of 0.13. The stock has a 50 day moving average price of $76.84 and a 200 day moving average price of $80.67. Stericycle has a one year low of $71.52 and a one year high of $90.45.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The company had revenue of $917.70 million during the quarter, compared to the consensus estimate of $902.81 million. During the same quarter in the previous year, the firm earned $1.18 EPS. The company’s revenue was up 2.9% on a year-over-year basis. Equities research analysts expect that Stericycle will post $4.60 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Stericycle, Inc. (NASDAQ:SRCL) Earns “Buy” Rating from Jefferies Group LLC” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/08/stericycles-nasdaqsrcl-buy-rating-reiterated-at-jefferies-group-llc-updated-updated-updated.html.

Several hedge funds and other institutional investors have recently made changes to their positions in SRCL. Kernodle & Katon Asset Management Group LLC acquired a new position in shares of Stericycle during the first quarter valued at approximately $100,000. Heritage Trust Co acquired a new position in shares of Stericycle during the first quarter valued at approximately $124,000. Pacer Advisors Inc. raised its position in shares of Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares during the period. Invictus RG acquired a new position in shares of Stericycle during the first quarter valued at approximately $145,000. Finally, Morgan Dempsey Capital Management LLC raised its position in shares of Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares during the period. Institutional investors own 95.16% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.